Advertisement

Psoriasis

  • Robert A. Norman
  • Edward M. YoungJr
Chapter

Abstract

Psoriasis is a common, noncontagious, multisystem, inflammatory dermatosis of the skin. The cause is unknown but studies suggest a genetic predisposition for the disorder. It commonly manifests itself on the skin of scalp, lumbosacral areas, intergluteal clefts, pubic regions, and joints such as elbows, knees, wrists, and ankles. Psoriasis affects 1–2 % of the world’s population. It may begin at any age, but is more common in the second or third decade of life. Multiple types of psoriasis have been identified and distinguished by location and involvement:

Keywords

Psoriatic Arthritis Plaque Psoriasis Streptococcal Pharyngitis Inflammatory Dermatosis Scalp Psoriasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57:1–27.PubMedCrossRefGoogle Scholar
  2. 2.
    Augustin M, Kurger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology. 2008;216:366–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis. 2005;64:14–7.Google Scholar
  4. 4.
    Leung YY, Tam LS, Kun EW, Li EK. Psoriatic arthritis as a distinct disease entity. J Postgrad Med. 2007;53:63–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Riveira-Munoz E, He SM, Escaramís G, et al. Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol. 2011;131(5):1105–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. Jan 2005;52(1):23–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Pardasani AG, Feldman SR, Clark AR. Treatment of psoriais: and algorithm-based approach for primary care physicians. Am Fam Physician. 2000;61:725–33.PubMedGoogle Scholar
  8. 8.
    Kyle S, Chandler D, Griffitchs DEM, et al. Guideline for anti-TNF-a therapy in psoriatic arthritis. Rheumatology. 2005;44:390–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol. Aug 2008;159 Suppl 2:2–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Robert A. Norman
    • 1
  • Edward M. YoungJr
    • 2
  1. 1.Dermatology HealthcareTampaUSA
  2. 2.TarzanaUSA

Personalised recommendations